Alexandra Feetham is a product development, innovation, and strategy consultant specialising in precision medicine and radiopharmaceuticals. With over seven years of global oncology experience, she has held senior leadership roles at GenesisCare, including Global VP of Strategy & Innovation, VP of Corporate Development, and Strategic Projects Manager to the Office of the CEO. Alex combines clinical curiosity and expertise with an in-depth knowledge of emerging technology and financial and technical proficiency, to build understanding and rapport across commercial and clinical counterparts. She excels in research, problem-solving, analytics, and critical thinking, to develop and scale industry-leading healthcare solutions. Before transitioning into healthcare, Alex held positions in leveraged finance and structured equity at Deutsche Bank and conducted honours-level immunology research at Westmead Millennium Institute.
